Abstract:Mycobacterium tuberculosis, the causative agent of tuberculosis, has been a serious threat to public health. The recent emergence of extreme drug-resistant strains further worsened the situation and required more serious efforts to find a better cure for TB. Availability of the complete genome map of various Mycobacterium tuberculosis strains serves a basis to propose new therapeutic targets against Mycobacterium tuberculosis. The present study aimed to identify and characterize potential and novel drug target against Mycobacterium tuberculosis by using an in silico approach. The study consisted of three phases. In phase I, subtractive/comparative genomics was performed on genomic data of 17 strains of Mycobacterium tuberculosis comprised of 66,988 protein sequences. The analysis resulted in three identical hypothetical proteins of distinct origin. The shortlisted sequences were non-homologous to the host, a prerequisite characteristic of potential drug target. One of the sequences, i.e., WP_003901628.1 (the locus tag name is CFBR_RS17985) from the CDC5180 strain was further subjected to other bioinformatics methods in phase II. In phase II, the shortlisted protein sequence was qualitatively characterized for subcellular localization, functional family prediction and evolutionary relationships. The predicted subcellular localization of the query protein was found in cytoplasmic region. The functional family classification resulted in classifying the protein in transferase superfamily. Finally, in phase III of the study, the structure-based methods (i.e., homology modeling and docking) were performed to build the three-dimensional (3D) structure and to predict the putative binding site. The PDB-ID 3DR4 was found to be a suitable template having 30.1% sequence identity. The binding site of modeled protein was deciphered with DoGSite scorer tool. Later on, the ProBis tool was used to probe structurally similar binding sites in Protein Data Bank. Subsequently, the co-crystal ligands of the Protein Data Bank structures (prioritized by high-rank Z scores) were extracted and cross-docked into the binding site of the modeled protein. The cross-docking results revealed two ligands, i.e., 4′-deoxy-4′-aminopyridoxal-5′-phosphate and OG1 from two Protein Data Bank structures, i.e., 1MDO and 4K2M as best docked with RMSDs 2.8 and 2.5 Å, respectively. It is inferred from the protein structure that the identified protein is alanine-rich with a PI < 7. Current study convincingly proposed that the shortlisted hypothetical protein (WP_003901628.1) is a potential drug target against which new drug candidates could be designed in a hope to cure tuberculosis.

A Novel Actinobacteria-Specific Ribosome Hibernation Factor in Mycobacterium tuberculosis

Structural Basis of Mycobacterium Tuberculosis Transcription and Transcription Inhibition

Cryo- EM structure of the mycobacterial 70S ribosome in complex with ribosome hibernation promotion factor RafH

VapC toxin switches M. smegmatis cells into dormancy through 23S rRNA cleavage

Cryo-EM Structure of Mycobacterium Tuberculosis 50S Ribosomal Subunit Bound with Clarithromycin Reveals Dynamic and Specific Interactions with Macrolides

Structural insights into transcription regulation of the global virulence factor PhoP from Mycobacterium tuberculosis

Cryo-EM structure of transcription termination factor Rho from Mycobacterium tuberculosis reveals bicyclomycin resistance mechanism

Putative TetR family transcriptional regulator Rv1019 of Mycobacterium tuberculosis is an auto-repressor and a negative regulator of mfd-mazG operon

Mycobacterium tuberculosis F-ATP Synthase Inhibitors and Targets

Structural insights of the elongation factor EF-Tu complexes in protein translation of Mycobacterium tuberculosis

Cryo-EM structures of a mycobacterial ABC transporter that mediates rifampicin resistance

The Structural and Molecular Mechanisms of Mycobacterium tuberculosis Translational Elongation Factor Proteins

Rv0547c, a functional oxidoreductase, supports Mycobacterium tuberculosis persistence by reprogramming host mitochondrial fatty acid metabolism

Ribosome-inactivation by a class of widely distributed C-tail anchored membrane proteins

Deciphering a Sleeping Pathogen: Uncovering Novel Transcriptional Regulators of Hypoxia-Induced Dormancy in Mycobacterium Tuberculosis

A new family of bacterial ribosome hibernation factors

Structural and functional characterization of mycobacterial PhoH2 and identification of potential inhibitor of its enzymatic activity

Structural and functional characterization of a unique hypothetical protein (WP_003901628.1) of Mycobacterium tuberculosis: a computational approach

Computational analysis of RNA methyltransferase Rv3366 as a potential drug target for combating drug-resistant Mycobacterium tuberculosis

[PRIMARY DEFLEXION OF THE FETAL HEAD IN BREECH PRESENTATION. DIAGNOSTIC, PATHOGENIC AND THERAPEUTIC PROBLEMS].

Structural Insights into the Complex of Trigger Factor Chaperone and Ribosomal Protein S7 from Mycobacterium Tuberculosis.